Evolution of the hypoxia-sensitive cells involved in amniote respiratory reflexes
The evolutionary origins of the hypoxia-sensitive cells that trigger amniote respiratory reflexes - carotid body glomus cells, and 'pulmonary neuroendocrine cells' (PNECs) - are obscure. Homology has been proposed between glomus cells, which are neural crest-derived, and the hypoxia-sensit...
Saved in:
Published in | eLife Vol. 6 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
eLife Science Publications, Ltd
07.04.2017
eLife Sciences Publications Ltd eLife Sciences Publications, Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The evolutionary origins of the hypoxia-sensitive cells that trigger amniote respiratory reflexes - carotid body glomus cells, and 'pulmonary neuroendocrine cells' (PNECs) - are obscure. Homology has been proposed between glomus cells, which are neural crest-derived, and the hypoxia-sensitive 'neuroepithelial cells' (NECs) of fish gills, whose embryonic origin is unknown. NECs have also been likened to PNECs, which differentiate in situ within lung airway epithelia. Using genetic lineage-tracing and neural crest-deficient mutants in zebrafish, and physical fate-mapping in frog and lamprey, we find that NECs are not neural crest-derived, but endoderm-derived, like PNECs, whose endodermal origin we confirm. We discover neural crest-derived catecholaminergic cells associated with zebrafish pharyngeal arch blood vessels, and propose a new model for amniote hypoxia-sensitive cell evolution: endoderm-derived NECs were retained as PNECs, while the carotid body evolved via the aggregation of neural crest-derived catecholaminergic (chromaffin) cells already associated with blood vessels in anamniote pharyngeal arches. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Department of Developmental Biology, Washington University School of Medicine, St. Louis, United States. Department of Mechanical Engineering, California NanoSystem Institute, University of California, Santa Barbara, Santa Barbara, United States. Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, United States. Division of Oncology, Washington University School of Medicine, St. Louis, United States. Department of Medicine, Washington University School of Medicine, St. Louis, United States. Gastrointestinal Drug Discovery Unit, Takeda Pharmaceuticals United States, Inc., Cambridge, United States. Institute of Molecular Life Sciences, University of Zürich, Zürich, Switzerland. |
ISSN: | 2050-084X 2050-084X |
DOI: | 10.7554/elife.21231 |